ArticleRespiratory research2026
Clinical subtypes of co-morbid insomnia and obstructive sleep apnea (COMISA): results of a cluster analysis.
Article in Respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Factors associated with sleep state misperception in patients with obstructive sleep apnea: a cross-sectional study.Frontiers in neurology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundVariations in the bidirectional relationship between obstructive sleep apnea (OSA) and insomnia in co-morbid insomnia and OSA (COMISA) may form distinct subtypes of COMISA, which have not been previously characterized. This study aims to identify and characterize subtypes of COMISA.
methodsFrom a community-recruited COMISA cohort 256 individuals who met diagnosis for COMISA were used to identify subtypes using a two-step clustering methodology. Demographics and multidimension clinical characteristics were collected and compared among obtained subtypes. Logistic models were used to evaluate whether these subtypes were associated with cardiometabolic and mental disorders. A clinical cohort of 1816 COMISA patients was used to validate the determined clusters applying the same two-step clustering methodology.
resultsCluster analysis yielded three clusters (COMISA subtypes): “moderate OSA and moderate insomnia” (cluster 1), “moderate OSA and severe insomnia” (Cluster 2) and “severe OSA and moderate insomnia” (Cluster 3), consisting of 58.2%, 21.9% and 19.9% of the entire cohort, which was validated using the clinical COMISA cohort. The clusters differed significantly on a variety of clinical measurements, including blood indicators related to cardiometabolic risk, inflammation and liver function, depression symptoms, and encephalogram (EEG) spectral power. Cluster 2 was associated with elevated risk of moderate-to-severe depression symptoms, while Cluster 3 was associated with increased risk of CVD and metabolic syndrome.
conclusionThese findings provide important preliminary evidence of the existence of phenotypes of COMISA which are likely to have clinical relevance and provide a foundation in precision medicine for treatment of COMISA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.